


Searching News Database: neural stem cell
HSMN NewsFeed - 20 May 2016
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
HSMN NewsFeed - 24 Mar 2015
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
HSMN NewsFeed - 12 Oct 2011
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
HSMN NewsFeed - 9 Feb 2011
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
HSMN NewsFeed - 25 Aug 2010
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
HSMN NewsFeed - 10 Sep 2009
StemCells, Inc. to Initiate First Ever Neural Stem Cell Trial in Myelination Disorder
StemCells, Inc. to Initiate First Ever Neural Stem Cell Trial in Myelination Disorder
HSMN NewsFeed - 18 Dec 2008
StemCells, Inc. Receives FDA Approval To Initiate Clinical Trial Of HuCNS-SCĀ® Cells In A Myelin Disease
StemCells, Inc. Receives FDA Approval To Initiate Clinical Trial Of HuCNS-SCĀ® Cells In A Myelin Disease
HSMN NewsFeed - 29 May 2008
StemCells Confirms Previously Reported Batten Trial Death Was Due to Natural Progression of Disease
StemCells Confirms Previously Reported Batten Trial Death Was Due to Natural Progression of Disease
HSMN NewsFeed - 20 Feb 2008
Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
HSMN NewsFeed - 20 Nov 2007
Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials
Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials
HSMN NewsFeed - 19 Sep 2007
Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc.
Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc.
HSMN NewsFeed - 18 Jun 2007
StemCells, Inc. Announces Important Milestone in Batten Disease Clinical Trial
StemCells, Inc. Announces Important Milestone in Batten Disease Clinical Trial
HSMN NewsFeed - 30 May 2007
Neuralstem's Cells Restore Motor Function in Spinal Ischemia-Paralyzed Rats
Neuralstem's Cells Restore Motor Function in Spinal Ischemia-Paralyzed Rats
HSMN NewsFeed - 24 Apr 2007
William C. Oldaker and Scott V. Ogilvie Join Neuralstem Board of Directors
William C. Oldaker and Scott V. Ogilvie Join Neuralstem Board of Directors
HSMN NewsFeed - 20 Feb 2007
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
Additional items found! 10
Members Archive contains
10 additional stories matching:
neural stem cell
(Password required)
neural stem cell
(Password required)
